aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study
January 30, 2019 16:00 ET
|
aTyr Pharma, Inc.
Collaboration to advance neuropilin-2 biology and explore potential therapeutic opportunities for ATYR1923 Reinforces aTyr’s commitment to working with a strategic network of leading academic...
Pangu BioPharma (an aTyr Pharma Subsidiary) and The Hong Kong University of Science and Technology Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease
January 16, 2019 16:00 ET
|
aTyr Pharma, Inc.
Researchers from The Hong Kong University of Science and Technology credited with important translational science and early discovery work Significant opportunity to replicate collaborative model to...
aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR)
December 04, 2018 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma to Present at the BMO 2018 Prescriptions for Success Healthcare Conference
November 28, 2018 20:16 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting
October 17, 2018 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma Announces Leadership Transition
October 15, 2018 16:30 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma Announces Pulmonary Sarcoidosis as Disease Indication for Phase 1b/2a Clinical Study and Educational Webinar
September 27, 2018 16:05 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
September 20, 2018 16:38 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
aTyr Pharma Announces Leadership Transition
November 01, 2017 16:05 ET
|
aTyr Pharma, Inc.
– Dr. John Mendlein Transitions from CEO to Non-Executive Board Member,Dr. Sanjay Shukla Appointed President and CEO – SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE),...
Elev8 Brands, Inc. and 1 OAK Wholesale Come to Terms on Vape and Smoke Shop National Distribution Agreement
August 29, 2017 09:26 ET
|
Elev8 Brands, Inc.
ROCKLEDGE, Fla., Aug. 29, 2017 (GLOBE NEWSWIRE) -- Elev8 Brands, Inc. (OTC Pink:VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee,...